[{"from": "human", "value": "Please give me some details about this molecule. [C][C][C][N][C][C@@H1][Branch2][Ring1][=Branch1][C][C@H1][C@H1][Ring1][=Branch1][C][C][=C][N][C][=C][C][=C][C][Ring1][O][=C][Ring1][=Branch2][Ring1][=Branch1][C][S][C][C][=Branch1][C][=O][N][C][C][C][C][C@H1][Branch2][Branch2][O][C][=Branch1][C][=O][N][C@H1][C][S][S][C][C@H1][Branch2][=Branch1][O][N][C][=Branch1][C][=O][C@@H1][Branch2][Branch1][S][N][C][=Branch1][C][=O][C@@H1][Branch2][Branch1][C][N][C][=Branch1][C][=O][C@H1][Branch2][Ring1][O][N][C][=Branch1][C][=O][C@@H1][Branch1][#Branch1][N][C][Ring2][Ring1][Branch2][=O][C][C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][O][C][C][=C][N][C][=C][C][=C][C][=C][Ring1][=Branch1][Ring1][=Branch2][C][C][C][C][N][C][C][C][=Branch1][C][=O][N][C@@H1][Branch1][=Branch1][C@@H1][Branch1][C][C][O][C][=Branch1][C][=O][N][N][C][=Branch1][C][=O][C][S][C][C@@H1][C][C@H1][C@@H1][Branch1][P][C][C][=C][N][C][=C][C][=C][C][Ring1][O][=C][Ring1][=Branch2][Ring1][=Branch1][N][Branch1][Ring2][C][Ring1][S][C][C][C]"}, {"from": "gpt", "value": "The molecule is a chimeric dopamine (DA)-somatostatin (SST) compound, with potential antineoplastic activity. Upon administration, onzigolide binds with high affinity to dopamine D2 receptor (D2R) and somatostatin receptor subtype 2 (SSTR2), and to a lesser extent to somatostatin receptor subtype 5 (SSTR5). This agent appears to exert its effect mainly by binding to D2R to activate the ERK1/2 and p38 MAPK pathways, thus inducing apoptosis and inhibiting cellular proliferation in non-functioning pituitary adenoma (NFPA) and neuroendocrine tumors. By binding to SSTR2, this agent may inhibit the secretion of growth hormone (GH) by the pituitary gland."}]